Iyah Chen

Iyah Chen is a patent litigation associate with a practice primarily focused on complex disputes within the pharmaceutical and biotechnology sectors. Her work includes extensive experience in Hatch-Waxman patent infringement litigations, alongside conducting diligences concerning patent validity and freedom-to-operate analyses for new technologies. Her experience includes representing plaintiffs, as evidenced by her appearance in a significant pharmaceutical patent case.

Currently, Ms. Chen is an associate in the New York office of Quinn Emanuel Urquhart & Sullivan LLP. Prior to joining Quinn Emanuel, she was an attorney at Patterson Belknap Webb & Tyler LLP, where she represented Veloxis Pharmaceuticals, Inc. as a plaintiff in the patent infringement case Veloxis Pharmaceuticals, Inc. v. Glenmark Pharmaceuticals Inc., USA, filed in the U.S. District Court for the District of Delaware.

While her professional profile notes experience with patent validity, it does not explicitly detail regular appearances in Inter Partes Review (IPR) or Post-Grant Review (PGR) proceedings before the Patent Trial and Appeal Board (PTAB). Ms. Chen is admitted to the New York State Bar. She earned her J.D. from the University of Maryland Francis King Carey School of Law in 2019, an M.S. in Biotechnology from Johns Hopkins University in 2016, and a B.S. in Neurobiology, Physiology, and Behavior from the University of California, Davis in 2011.